Australia Health Journal Speaks to Prof Simon Lewis and Clyde Campbell

World Parkinson’s Day is on April 11th 2018 and Australian Health Journal spoke with Professor Simon Lewis of the Brain And Mind Centre, University of Sydney and CEO and Founder of Shake It Up Australia Foundation, Clyde Campbell.

Parkinson’s affects people under 50 as well as those over 50. Those that are under 50 make up approximately 30% of cases. A cure is yet to be found. As part of the Linked Clinical Trials Initiative, a number of Institutes and Foundations including Shake It Up and The Michael J. Fox Foundation for Parkinson’s Research collaborate to determine areas to focus research in the search for a cure for Parkinson’s. 

In Australia, oOh!media is helping the Shake It Up Foundation raise awareness for Parkinson’s through their digital displays across Australia and at a launch event on April 11th. This clip is early release footage for the general Australian population, is from a segment to be aired in the May Edition of Australian Health Journal. 

 

Professor Lewis speaks about the research into Parkinson’s using existing drugs for other conditions. He also talks about the current treatments available including Deep Brain Stimulation.

World Parkinson’s Day is on today, April 11th 2018 and Australian Health Journal spoke with Professor Simon Lewis of the Brain And Mind Centre, part of University of Sydney.

About the Linked Clinical Trials Initiative (LCT):

As part of the Linked Clinical Trials Initiative (LCT), a number of Institutes and Foundations including Garvan Institute of Medical Research, Van Andel Institute, Shake It Up Australia Foundation and The Michael J. Fox Foundation for Parkinson’s Research collaborate to determine areas to focus research in the search for a cure to Parkinson’s.

“The LCT scientific committee prioritises new treatments once a year to identify the most promising drugs to fast-track into clinical trials, with the hope of not only proving efficacy but also shortening the time it takes for a potential treatment to move from the laboratory to clinical trials and, ultimately, to the patient.”

Find out more about the Linked Clinical Trials underway in Australia.